| Abbreviation . | Full name . |
|---|---|
| ABC . | Aging Biomarker Consortium . |
| COR | Class of recommendation |
| LOE | Level of evidence |
| MCI | Mild cognitive impairment |
| AD | Alzheimer’s disease |
| TMT | Trail making test |
| AVLT | Auditory verbal learning test |
| fMRI | Functional magnetic resonance imaging |
| MRI | Magnetic resonance imaging |
| WMH | White matter hyperintensities |
| TIWI | T1-weighted image |
| T2WI | T2-weighted image |
| FLAIR | Fluid-attenuated inversion recovery |
| SWI | Susceptibility weighted imaging |
| DTI | Diffusion tensor imaging |
| DMN | default-mode network |
| FDG | 18F-fluorodeoxyglucose |
| OCT | Optical coherence tomography |
| CSF | Cerebrospinal fluid |
| p-tau | Hyperphosphorylated tau |
| t-tau | Total tau |
| NfL | Neurofilament light chain |
| TREM2 | Triggering receptor expressed on myeloid cells 2 |
| sTREM2 | Soluble triggering receptor expressed on myeloid cells 2 |
| GFAP | Glial fibrillary acidic protein |
| SASP | Senescence-associated secretory phenotype |
| sPDGFRβ | Soluble platelet-derived growth factor receptor beta |
| ALCAM | Activated leukocyte cell adhesion molecule |
| FSH | Follicle-stimulating hormone |
| IGF-1 | Insulin-like growth factor 1 |
| NAD | Nicotinamide adenine dinucleotide |
| NADH | Nicotinamide adenine dinucleotide reduced |
| GDF11 | Growth differentiation factor 11 |
| GAPDH | Reduced glyceraldehyde-phosphate dehydrogenase |
| Abbreviation . | Full name . |
|---|---|
| ABC . | Aging Biomarker Consortium . |
| COR | Class of recommendation |
| LOE | Level of evidence |
| MCI | Mild cognitive impairment |
| AD | Alzheimer’s disease |
| TMT | Trail making test |
| AVLT | Auditory verbal learning test |
| fMRI | Functional magnetic resonance imaging |
| MRI | Magnetic resonance imaging |
| WMH | White matter hyperintensities |
| TIWI | T1-weighted image |
| T2WI | T2-weighted image |
| FLAIR | Fluid-attenuated inversion recovery |
| SWI | Susceptibility weighted imaging |
| DTI | Diffusion tensor imaging |
| DMN | default-mode network |
| FDG | 18F-fluorodeoxyglucose |
| OCT | Optical coherence tomography |
| CSF | Cerebrospinal fluid |
| p-tau | Hyperphosphorylated tau |
| t-tau | Total tau |
| NfL | Neurofilament light chain |
| TREM2 | Triggering receptor expressed on myeloid cells 2 |
| sTREM2 | Soluble triggering receptor expressed on myeloid cells 2 |
| GFAP | Glial fibrillary acidic protein |
| SASP | Senescence-associated secretory phenotype |
| sPDGFRβ | Soluble platelet-derived growth factor receptor beta |
| ALCAM | Activated leukocyte cell adhesion molecule |
| FSH | Follicle-stimulating hormone |
| IGF-1 | Insulin-like growth factor 1 |
| NAD | Nicotinamide adenine dinucleotide |
| NADH | Nicotinamide adenine dinucleotide reduced |
| GDF11 | Growth differentiation factor 11 |
| GAPDH | Reduced glyceraldehyde-phosphate dehydrogenase |
| Abbreviation . | Full name . |
|---|---|
| ABC . | Aging Biomarker Consortium . |
| COR | Class of recommendation |
| LOE | Level of evidence |
| MCI | Mild cognitive impairment |
| AD | Alzheimer’s disease |
| TMT | Trail making test |
| AVLT | Auditory verbal learning test |
| fMRI | Functional magnetic resonance imaging |
| MRI | Magnetic resonance imaging |
| WMH | White matter hyperintensities |
| TIWI | T1-weighted image |
| T2WI | T2-weighted image |
| FLAIR | Fluid-attenuated inversion recovery |
| SWI | Susceptibility weighted imaging |
| DTI | Diffusion tensor imaging |
| DMN | default-mode network |
| FDG | 18F-fluorodeoxyglucose |
| OCT | Optical coherence tomography |
| CSF | Cerebrospinal fluid |
| p-tau | Hyperphosphorylated tau |
| t-tau | Total tau |
| NfL | Neurofilament light chain |
| TREM2 | Triggering receptor expressed on myeloid cells 2 |
| sTREM2 | Soluble triggering receptor expressed on myeloid cells 2 |
| GFAP | Glial fibrillary acidic protein |
| SASP | Senescence-associated secretory phenotype |
| sPDGFRβ | Soluble platelet-derived growth factor receptor beta |
| ALCAM | Activated leukocyte cell adhesion molecule |
| FSH | Follicle-stimulating hormone |
| IGF-1 | Insulin-like growth factor 1 |
| NAD | Nicotinamide adenine dinucleotide |
| NADH | Nicotinamide adenine dinucleotide reduced |
| GDF11 | Growth differentiation factor 11 |
| GAPDH | Reduced glyceraldehyde-phosphate dehydrogenase |
| Abbreviation . | Full name . |
|---|---|
| ABC . | Aging Biomarker Consortium . |
| COR | Class of recommendation |
| LOE | Level of evidence |
| MCI | Mild cognitive impairment |
| AD | Alzheimer’s disease |
| TMT | Trail making test |
| AVLT | Auditory verbal learning test |
| fMRI | Functional magnetic resonance imaging |
| MRI | Magnetic resonance imaging |
| WMH | White matter hyperintensities |
| TIWI | T1-weighted image |
| T2WI | T2-weighted image |
| FLAIR | Fluid-attenuated inversion recovery |
| SWI | Susceptibility weighted imaging |
| DTI | Diffusion tensor imaging |
| DMN | default-mode network |
| FDG | 18F-fluorodeoxyglucose |
| OCT | Optical coherence tomography |
| CSF | Cerebrospinal fluid |
| p-tau | Hyperphosphorylated tau |
| t-tau | Total tau |
| NfL | Neurofilament light chain |
| TREM2 | Triggering receptor expressed on myeloid cells 2 |
| sTREM2 | Soluble triggering receptor expressed on myeloid cells 2 |
| GFAP | Glial fibrillary acidic protein |
| SASP | Senescence-associated secretory phenotype |
| sPDGFRβ | Soluble platelet-derived growth factor receptor beta |
| ALCAM | Activated leukocyte cell adhesion molecule |
| FSH | Follicle-stimulating hormone |
| IGF-1 | Insulin-like growth factor 1 |
| NAD | Nicotinamide adenine dinucleotide |
| NADH | Nicotinamide adenine dinucleotide reduced |
| GDF11 | Growth differentiation factor 11 |
| GAPDH | Reduced glyceraldehyde-phosphate dehydrogenase |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
